Copyright © 2012 Soo-Jung Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. A. J. Lusis, “Atherosclerosis,” Nature, vol. 407, no. 6801, pp. 233–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
2. R. Ross, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, no. 6423, pp. 801–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
3. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
4. J. Yao, N. Mackman, T. S. Edgington, and S. T. Fan, “Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells: regulation by Egr-1, c-Jun, and NF-κB transcription factors,” The Journal of Biological Chemistry, vol. 272, no. 28, pp. 17795–17801, 1997. View at Publisher · View at Google Scholar · View at Scopus
5. B. Diaz and G. Lopez-Berestein, “A distinct element involved in lipopolysaccharide activation of the tumor necrosis factor-α promoter in monocytes,” Journal of Interferon and Cytokine Research, vol. 20, no. 8, pp. 741–748, 2000. View at Publisher · View at Google Scholar · View at Scopus
6. F. Chen, V. Castranova, X. Shi, and L. M. Demers, “New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases,” Clinical Chemistry, vol. 45, no. 1, pp. 7–17, 1999. View at Scopus
7. M. P. J. De Winther, E. Kanters, G. Kraal, and M. H. Hofker, “Nuclear factor κB signaling in atherogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 904–914, 2005. View at Publisher · View at Google Scholar · View at Scopus
8. A. Mullen, C. E. Loscher, and H. M. Roche, “Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages,” Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 444–450, 2010. View at Publisher · View at Google Scholar · View at Scopus
9. C. S. Chang, H. L. Sun, C. K. Lii, H. W. Chen, P. Y. Chen, and K. L. Liu, “Gamma-linolenic acid inhibits inflammatory responses by regulating nf-κB and AP-1 activation in lipopolysaccharide-induced RAW 264.7 macrophages,” Inflammation, vol. 33, no. 1, pp. 46–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
10. P. P. Liu, J. Le, and M. Nian, “Nuclear factor-κB decoy: infiltrating the heart of the matter in inflammatory heart disease,” Circulation Research, vol. 89, no. 10, pp. 850–852, 2001. View at Scopus
11. P. P. Tak, D. M. Gerlag, K. R. Aupperle et al., “Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation,” Arthritis and Rheumatism, vol. 44, no. 8, pp. 1897–1907, 2001. View at Publisher · View at Google Scholar · View at Scopus
12. P. Kapahi, T. Takahashi, G. Natoli et al., “Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase,” The Journal of Biological Chemistry, vol. 275, no. 46, pp. 36062–36066, 2000. View at Publisher · View at Google Scholar · View at Scopus
13. D. J. Son, J. W. Lee, Y. H. Lee, H. S. Song, C. K. Lee, and J. T. Hong, “Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds,” Pharmacology and Therapeutics, vol. 115, no. 2, pp. 246–270, 2007. View at Publisher · View at Google Scholar · View at Scopus
14. W. R. Lariviere and R. Melzack, “The bee venom test: a new tonic-pain test,” Pain, vol. 66, no. 2-3, pp. 271–277, 1996. View at Publisher · View at Google Scholar · View at Scopus
15. B. E. C. Banks, C. Brown, and G. M. Burgess, “Apamin blocks certain neurotransmitter-induced increases in potassium permeability,” Nature, vol. 282, no. 5737, pp. 415–417, 1979.
16. G. B. J. Mancini, “Antiatherosclerotic effects of calcium channel blockers,” Progress in Cardiovascular Diseases, vol. 45, no. 1, pp. 1–20, 2002. View at Publisher · View at Google Scholar · View at Scopus
17. G. S. Getz, “Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis.,” Journal of Lipid Research, vol. 46, no. 1, pp. 1–10, 2005. View at Scopus
18. K. W. Nam, K. H. Je, H. L. Jang et al., “Inhibition of COX-2 activity and proinflammatory cytokines (TNF-α and IL-1β) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom,” Archives of Pharmacal Research, vol. 26, no. 5, pp. 383–388, 2003. View at Scopus
19. S. Han, K. Lee, J. Yeo et al., “Effect of venom from the Asian honeybee (Apis cerana Fab.) on LPS-induced nitric oxide and tumor necrosis factor-α production in RAW 264.7 cell line,” Journal of Apicultural Research, vol. 45, no. 3, pp. 131–136, 2006. View at Scopus
20. W. R. Lee, S. J. Kim, J. H. Park et al., “Bee venom reduces atherosclerotic lesion formation via anti-inflammatory mechanism,” American Journal of Chinese Medicine, vol. 38, no. 6, pp. 1077–1092, 2010. View at Publisher · View at Google Scholar · View at Scopus
21. H. W. Kim, Y. B. Kwon, T. W. Ham et al., “General pharmacological profiles of bee venom and its water soluble fractions in rodent models,” Journal of Veterinary Science, vol. 5, no. 4, pp. 309–318, 2004. View at Scopus
22. R. Ovcharov, S. Shkenderov, and S. Mihailova, “Anti inflammatory effects of apamin,” Toxicon, vol. 14, no. 6, pp. 441–447, 1976. View at Scopus
23. H. Sumikura, O. K. Andersen, A. M. Drewes, and L. Arendt-Nielsen, “A comparison of hyperalgesia and neurogenic inflammation induced by melittin and capsaicin in humans,” Neuroscience Letters, vol. 337, no. 3, pp. 147–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
24. P. M. Ridker, N. Rifai, M. Pfeffer, F. Sacks, S. Lepage, and E. Braunwald, “Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction,” Circulation, vol. 101, no. 18, pp. 2149–2153, 2000. View at Scopus
25. A. S. Baldwin, “NF kappa B: biology and pathology,” IDrugs, vol. 7, no. 3, pp. 215–216, 2004. View at Scopus
26. T. Collins and M. I. Cybulsky, “NF-κB: pivotal mediator or innocent bystander in atherogenesis?” The Journal of Clinical Investigation, vol. 107, no. 3, pp. 255–264, 2001. View at Scopus
27. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” The Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Scopus
28. S. J. Kim, J. H. Park, K. H. Kim et al., “Effect of NF-κB decoy oligodeoxynucleotide on LPS/high-fat diet-induced atherosclerosis in an animal model,” Basic and Clinical Pharmacology and Toxicology, vol. 107, no. 6, pp. 925–930, 2010. View at Publisher · View at Google Scholar · View at Scopus
29. Y. Ning, Q. Bai, H. Lu et al., “Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages,” Atherosclerosis, vol. 204, no. 1, pp. 114–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
30. C. Popa, M. G. Netea, P. L. C. M. Van Riel, J. W. M. Van Der Meer, and A. F. H. Stalenhoef, “The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk,” Journal of Lipid Research, vol. 48, no. 4, pp. 751–752, 2007. View at Publisher · View at Google Scholar · View at Scopus
31. C. Pollaud-Chérion, J. Vandaele, F. Quartulli, M. H. Séguélas, J. Decerprit, and B. Pipy, “Involvement of calcium and arachidonate metabolism in acetylated-low-density-lipoprotein-stimulated tumor-necrosis-factor-α production by rat peritoneal macrophages,” European Journal of Biochemistry, vol. 253, no. 1, pp. 345–353, 1998. View at Publisher · View at Google Scholar · View at Scopus
32. H. J. Jeong, S. H. Hong, D. J. Lee, J. H. Park, K. S. Kim, and H. M. Kim, “Role of Ca²⁺ on TNF-α and IL-6 secretion from RBL-2H3 mast cells,” Cellular Signalling, vol. 14, no. 7, pp. 633–639, 2002. View at Publisher · View at Google Scholar · View at Scopus
33. Y. Nakashima, E. W. Raines, A. S. Plump, J. L. Breslow, and R. Ross, “Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 5, pp. 842–851, 1998. View at Scopus
34. K. Iiyama, L. Hajra, M. Iiyama et al., “Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation,” Circulation Research, vol. 85, no. 2, pp. 199–207, 1999. View at Scopus
35. S. Xu, A. C. Liu, and A. I. Gotlieb, “Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-β,” Cardiovascular Pathology, vol. 19, no. 4, pp. 236–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
36. R. E. Feaver, B. D. Gelfand, C. Wang, M. A. Schwartz, and B. R. Blackman, “Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation,” Circulation Research, vol. 106, no. 11, pp. 1703–1711, 2010. View at Publisher · View at Google Scholar · View at Scopus
37. J. Roman, J. D. Ritzenthaler, M. J. Fenton, S. Roser, and W. Schuyler, “Transcriptional regulation of the human interleukin 1β gene by fibronectin: role of protein kinase C and activator protein 1 (AP-1),” Cytokine, vol. 12, no. 11, pp. 1581–1596, 2000. View at Publisher · View at Google Scholar · View at Scopus
38. L. Brånén, L. Hovgaard, M. Nitulescu, E. Bengtsson, J. Nilsson, and S. Jovinge, “Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 2137–2142, 2004. View at Publisher · View at Google Scholar · View at Scopus
39. Y. V. Bobryshev, “Monocyte recruitment and foam cell formation in atherosclerosis,” Micron, vol. 37, no. 3, pp. 208–222, 2006. View at Publisher · View at Google Scholar · View at Scopus